Literature DB >> 3757209

Production and certification of secondary enzyme reference materials (ERMs). Part 2: The need for meaningful protocols that assure photometric accuracy and a well-defined process for value assignment.

J C Koedam, H J van Dreumel, W v d Ham, G M Steentjes, J B Terlingen.   

Abstract

A collaborative study to assign values to two enzyme reference materials (ERMs) was performed by 18 laboratories whose spectrophotometers were checked by us, just before the study. We measured the wavelength accuracy and repeatability, the accuracy and linearity of the absorbance curves, the cuvette pathlength, equilibration time, equilibrium temperature, and a few other variables. Five spectrophotometers exhibited a marked wavelength-dependent nonlinearity. Most instruments were rather slow in bringing the sample to the correct temperature and the final temperature was often too high. In the collaborative study, each participant performed the same manual, well-described methods on four occasions in triplicate, using reagents prepared locally. The relation between the photometric checks and the analytical results is discussed, as well as the treatment of outliers and the effects on the variances. Suggestions are made about various facets of collaborative studies. The values assigned to the two ERMs carry a 95% uncertainty interval of +/- 1-4% of the mean.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3757209

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  1 in total

1.  Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.

Authors:  Mónica López-Guerra; Sílvia Xargay-Torrent; Patricia Fuentes; Jocabed Roldán; Blanca González-Farré; Laia Rosich; Elisabeth Silkenstedt; María J García-León; Eriong Lee-Vergés; Neus Giménez; Ariadna Giró; Marta Aymerich; Neus Villamor; Julio Delgado; Armando López-Guillermo; Xose S Puente; Elias Campo; María L Toribio; Dolors Colomer
Journal:  Oncogene       Date:  2019-10-15       Impact factor: 9.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.